According to the most recent financial data from June 2026, the EPS for the trailing twelve months is -$0.7. Bruker's EPS for 2025 amounted to -$0.15, marking a drop from $0.76 in 2024. During the quarterly period ending on Jun 30, 2026, BRKR's EPS stood at -$0.41.
Bruker had an annual EPS of -$0.15, indicating a drop of 119.7% from $0.76 in 2024. The quarterly per-share earnings for the period ending Jun 30, 2026, was -$0.41, indicating a 920% decrease from the same quarter last year. BRKR's 12-month EPS stands at -$0.7 as of June 2026. Bruker's annual EPS in 2024 stood at $0.76, a 74% decrease year-over-year.
Bruker has registered a decrease in EPS of 920% during the last 12 months (YoY, quarterly).
| Stock name | Price to Earnings | EPS grwoth 1Y | EPS grwoth 3Y | EPS grwoth 5Y |
|---|---|---|---|---|
| A Agilent Technologies Inc | 31.8 | 3.4% | 3.1% | 14.5% |
| TMO Thermo Fisher Scientific Inc | 33.8 | 7.2% | 0% | 2% |
| AME Ametek Inc | 34.92 | 7.9% | 8.4% | 11.1% |
| DHR Danaher Corp | 38.73 | -4.9% | -19.7% | 0.4% |
| ILMN Illumina Inc | 40.63 | 171.1% | N/A | 4.1% |
| GE General Electric Company | 40.75 | 35.8% | 447.4% | 12.1% |
| BIO Bio-Rad Laboratories Inc - Class A | 47.21 | 142.6% | N/A | -26.3% |
| WAT Waters Corp | 101.91 | 0.5% | -2.9% | 5.2% |
| BRKR Bruker Corp | N/A | -119.7% | N/A | N/A |
All data is based on quarterly TTM periods, unless otherwise specified.